Sengenics Buys Oxford Gene Technology's Protein Array Platform | GenomeWeb

NEW YORK (GenomeWeb) – Sengenics today announced it has acquired Oxford Gene Technology's protein array technology for an undisclosed amount. 

The technology, which will be rebranded Immunome, is an auto-antibody profiling platform developed as a joint collaboration between the University o fOxford and the University of Cambridge. It is the only array platform in which every protein is full length, correctly folded, and functionally validated, Sengenics said, adding that Immunome ensures that only correctly folded proteins are presented on the array. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.